Schedule 13G ownership disclosure
Apellis Pharmaceuticals Inc
Common Stock · CUSIP: 03753U106
Event date: 2025-03-31
- Filing-level shares
- 5,598,572.00
- Percent of class
- 4.5%
- BlackRock, Inc.
Shares: 5,598,572.00 · Class: 4.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-001714
- Form type
- SCHEDULE 13G/A
- Filer
- Apellis Pharmaceuticals, Inc.
- CIK
- CIK 1492422
- Filed
- Apr 25, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership